Trial NCT02150967

View at ClinicalTrials.gov 
Org. Study IDs: CBGJ398X2204
Secondary IDs: 2013-005085-19

Last trial update was posted on 2023-07-03

MeSH Interventions

Infigratinib

MeSH Conditions

Cholangiocarcinoma

Other Conditions

Advanced Cholangiocarcinoma FGFR2 Gene Mutation

Stopping Reasons

The study was terminated early due to limited efficacy in Cohorts 2 and 3 (exploratory endpoints). Termination was not due to concerns about safety and had no impact on the primary efficacy analysis (ie, results reported for Cohort 1).

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID